NCT03669055

Brief Summary

Aortic dissection (AD) is a serious pathology affecting one person for 300 000 habitants per year. In case of complicated AD on the descending aorta, it is necessary to perform an endovascular surgery in association with medical treatment. An endoprosthesis is implanted on the descending thoracic aorta in order to close the main intimal tear. This closure lead to an increase in the thoracic true lumen diameter, a decrease in the thoracic false lumen diameter, a better perfusion of the aortic branches. Furthermore, even in case of open surgical treatment of the ascending aorta it can be necessary to perform an endovascular treatment on the descending aorta, either to prevent and treat aneurysmal evolution or to treat patent malperfusion syndrome. CT and Magnetic Resonance angiography, by the realization of an aortic morphologic evaluation, are the two key imaging exams in the DA. Nevertheless, CT can't provide aortic dynamic evaluation, contrary to MRI. This exam, thanks to the phase-contrast sequence can measure velocity and flow data in vessels, including aorta but also true and false lumen in the AD. Thus, by verifying the perfusion of the aortic true lumen and the aortic branches it is possible to perform an early evaluation of the endovascular treatment of the DA. Actually, only one study has realized an aortic dynamic evaluation on the AD, unfortunately this study was limited to non-operated patients. In order to assess the place of MRI in the AD, the ingestigation propose to determine if phase-contrast MRI is able to evaluate the impact of the endovascular treatment on the hemodynamic state of the aorta and its branches.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 13, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

March 7, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2020

Completed
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

July 30, 2018

Last Update Submit

January 21, 2026

Conditions

Keywords

aortic dissectionhemodynamic4D flow phase contrast MRI

Outcome Measures

Primary Outcomes (1)

  • Comparative measurement of the flow in the aortic true lumen before and after endovascular treatment of the aortic dissection

    The flows are measured in ml/s at several locations of the aortic true lumen. The flows are measured during the two MRI and compared with each other.

    change from day 0 and day 16

Secondary Outcomes (7)

  • Comparative measurement of the flow in the aortic false lumen before and after endovascular treatment of the aortic dissection

    change from day 0 and day 16

  • Comparative measurement of the flow in the aortic branches before and after endovascular treatment of the aortic dissection

    day 0 and day 16

  • Comparative measurement of the number of intimal tear identified through 4D phase-contrast MRI relative to the number of intimal tear identified through Angio MRI before endovascular treatment of the aortic dissection

    change from day 0 and day 16

  • Flow measurement through intimal tear with 4 Dimensions (4D) phase-contrast MRI before and after endovascular treatment of the aortic dissection

    change from day 0 and day 16

  • Comparative measurement through 4D phase-contrast MRI of the shear forces before and after endovascular treatment of the aortic dissection

    change from day 0 and day 16

  • +2 more secondary outcomes

Study Arms (1)

Pre-operative and post operative Magnetic Resonance Imaging

EXPERIMENTAL

Realization of an angio-MRI with 4D phase contrast sequence before and after the endovascular treatment of the aortic dissection

Other: Magnetic Resonance Imaging

Interventions

Realization of a MRI before and after the endovascular treatment of the aortic dissection. Use of the 4D phase-contrast sequence during the MRI.

Pre-operative and post operative Magnetic Resonance Imaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with an aortic dissection requiring endovascular treatment
  • The endovascular treatment will be indicated according to the guidelines after medical, radiological and surgical multidisciplinary discussion in our hospital.
  • Patients that have signed the informed consent form.
  • Members of a social protection scheme.

You may not qualify if:

  • Patients with an aortic dissection requiring an emergency intervention
  • Patients with a contra-indication to endovascular treatment
  • Contra-indication to MRI: claustrophobia, ferromagnetic materials: pacemaker, prosthetic heart valve, implantable cardioverter defibrillators, vascular clip
  • Pregnancy
  • Breastfeeding
  • Dementia
  • Patients under guardianship
  • Patients with difficulty in understanding the French language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Louis Pradel

Bron, France

Location

MeSH Terms

Conditions

Aortic Dissection

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Dissection, Blood VesselAneurysmVascular DiseasesCardiovascular DiseasesAcute Aortic SyndromeAortic Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2018

First Posted

September 13, 2018

Study Start

March 7, 2019

Primary Completion

February 6, 2020

Study Completion

February 6, 2020

Last Updated

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations